We are live on ! Find out more
MSL

Mackay Shields LLC Portfolio holdings

AUM $2.73B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+12.38%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$13.8B
AUM Growth
+$1.47B
Cap. Flow
-$2.02B
Cap. Flow %
-14.66%
Top 10 Hldgs %
19.62%
Holding
1,500
New
123
Increased
507
Reduced
533
Closed
128

Top Buys

Rank Stock Value
1
MMIN icon
IQ MacKay Municipal Insured ETF
MMIN
+$21.2M
2
HES
Hess
HES
+$18.6M
3
SKX
Skechers
SKX
+$16.3M
4
AVGO icon
Broadcom
AVGO
+$15.2M
5
NKE icon
Nike
NKE
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 13.83%
2 Financials 9.68%
3 Healthcare 9.17%
4 Consumer Discretionary 8.93%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRA icon
1026
Atara Biotherapeutics
ATRA
$71.2M
$636K ﹤0.01%
640
+20
+3% +$18.6K
SIGA icon
1027
SIGA Technologies
SIGA
$223M
$633K ﹤0.01%
+105,300
New +$707K
VIAV icon
1028
Viavi Solutions
VIAV
$9.75B
$629K ﹤0.01%
50,800
RGNX icon
1029
Regenxbio
RGNX
$623M
$628K ﹤0.01%
10,957
+1,100
+11% +$54.5K
EXTN
1030
DELISTED
Exterran Corporation
EXTN
$626K ﹤0.01%
37,146
-22,400
-38% -$399K
RPAI
1031
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$624K ﹤0.01%
51,147
+6,021
+13% +$73.4K
RAMP icon
1032
LiveRamp
RAMP
$2.29B
$622K ﹤0.01%
+11,400
New +$565K
FNHC
1033
DELISTED
FedNat Holding Company Common Stock
FNHC
$622K ﹤0.01%
38,818
+5,300
+16% +$96.2K
BOLD
1034
DELISTED
Audentes Therapeutics, Inc
BOLD
$622K ﹤0.01%
15,953
+3,500
+28% +$100K
EVC icon
1035
Entravision Communication
EVC
$983M
$614K ﹤0.01%
189,419
-6,400
-3% -$23.7K
PTCT icon
1036
PTC Therapeutics
PTCT
$6.37B
$614K ﹤0.01%
16,327
+200
+1% +$6.71K
MOFG
1037
DELISTED
MidWestOne Financial Group
MOFG
$613K ﹤0.01%
22,474
EXPR
1038
DELISTED
Express, Inc.
EXPR
$613K ﹤0.01%
7,162
+2,660
+59% +$268K
ICUI icon
1039
ICU Medical
ICUI
$3.93B
$609K ﹤0.01%
2,548
-15,087
-86% -$3.62M
XNCR icon
1040
Xencor
XNCR
$1.44B
$606K ﹤0.01%
19,537
+200
+1% +$6.66K
ARWR icon
1041
Arrowhead Research
ARWR
$12.1B
$605K ﹤0.01%
33,000
HRTX icon
1042
Heron Therapeutics
HRTX
$86.3M
$598K ﹤0.01%
24,475
+500
+2% +$13.1K
MCFT icon
1043
MasterCraft Boat Holdings
MCFT
$588M
$582K ﹤0.01%
25,800
-6,300
-20% -$139K
TVTX icon
1044
Travere Therapeutics
TVTX
$5.33B
$580K ﹤0.01%
25,627
+4,700
+22% +$104K
CRUS icon
1045
Cirrus Logic
CRUS
$6.74B
$577K ﹤0.01%
+13,700
New +$529K
CVLT icon
1046
Commault Systems
CVLT
$5.89B
$564K ﹤0.01%
8,700
SHOE
1047
Shoe Station Group
SHOE
$395M
$559K ﹤0.01%
32,858
-40,788
-55% -$741K
RDUS
1048
DELISTED
Radius Health, Inc.
RDUS
$544K ﹤0.01%
27,282
-700
-3% -$12.8K
TPIC
1049
DELISTED
TPI Composites
TPIC
$543K ﹤0.01%
18,955
-35,800
-65% -$1.06M
TMX
1050
DELISTED
Terminix Global Holdings, Inc.
TMX
$533K ﹤0.01%
+11,420
New +$477K

Similar funds

Mackay Shields LLC's Q1 2019 Portfolio in Review

As of Q1 2019, Mackay Shields LLC held 1,500 positions worth $13.8B, up 12% from $12.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Mackay Shields LLC withdrew a net $2.02B in Q1 2019, closing 128 positions and reducing 533 holdings. Its most notable exit was Hess Corporation, an estimated $36.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mackay Shields LLC opened a new position in Toll Brothers worth $7.22M.

  • Mackay Shields LLC's largest Q1 2019 buy was Toll Brothers: 199,357 shares worth $7.22M.
  • Mackay Shields LLC added most to IQ MacKay Municipal Insured ETF in Q1 2019, an estimated $21.2M increase.
  • Mackay Shields LLC's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.8M.
  • Mackay Shields LLC fully exited Hess Corporation in Q1 2019, selling an estimated $36.9M.
  • Mackay Shields LLC's ten largest holdings make up 20% of its $13.8B portfolio in Q1 2019.
  • Mackay Shields LLC opened 123 new positions and closed 128 in Q1 2019.
  • Mackay Shields LLC's portfolio value rose 12% quarter-over-quarter to $13.8B.

Based on Mackay Shields LLC's 13F filing for Q1 2019, filed 13 May 2019.